EVLO - Evelo Biosciences, Inc.
Previous close
0.33
0.330 100.000%
Share volume: 0
Last Updated: Mon 11 Dec 2023 09:25:22 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
6%
Profitability
0%
Dept financing
10%
Liquidity
50%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-25.18%
Return on assets
-16.08%
Return on sales
0%
Return on invested capital
-255.51%
Total debt ratio
27.28%
Debt ratio change over timeo
-1.03%
Current Ratio
13.07%
Quick Ratio
0%
Cash Position Ratio
11.83%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-41.86%
Return on assets
-22.48%
Return on sales
0%
Return on invested capital
-3568.22%
Total debt ratio
44.4%
Debt ratio change over timeo
-1.09%
Current Ratio
6.57%
Quick Ratio
0%
Cash Position Ratio
6.88%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-41.49%
Return on assets
-19.25%
Return on sales
0%
Return on invested capital
-310.89%
Total debt ratio
51.9%
Debt ratio change over time
-1.19%
Current Ratio
6.24%
Quick Ratio
0%
Cash Position Ratio
6.02%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-97.58%
Return on assets
-98.86%
Return on sales
0%
Return on invested capital
-363.13%
Total debt ratio
-103.2%
Debt ratio change over time
-1.03%
Current Ratio
-1.52%
Quick Ratio
0%
Cash Position Ratio
-1.67%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | EVLO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -25.18% | -3.65% | 12.3% | 6.42% |
| Return on assets | -16.08% | 3.5% | 3.6% | 5.35% |
| Return on sales | 0% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | -255.51% | 4.99% | 7.81% | 13.62% |
| Profitability | 0% | 44% | 81% | 83% |
| Total debt ratio | 27.28% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | -1.03% | 224.03% | 6.03% | 1.46% |
| Dept financing | 7% | 50% | 19% | 8% |
| Current Ratio | 6.57% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 6.88% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 15% | 33% | 34% |
| Short-term ratios | EVLO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -41.86% | -16.17% | 18.05% | 7.63% |
| Return on assets | -22.48% | 2.71% | 3.58% | 5.03% |
| Return on sales | 0% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | -3568.22% | 6.54% | 5.97% | 19.39% |
| Profitability | 0% | 43% | 75% | 85% |
| Total debt ratio | 44.4% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | -1.09% | 851.68% | 10.97% | 0.58% |
| Dept financing | 11% | 50% | 21% | 8% |
| Current Ratio | 6.57% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 6.88% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 30% | 23% | 43% |